Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients
Vijayendra Dasari(QIMR Berghofer Medical Research Institute), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Daniel C. Chambers(Prince Charles Hospital), Yide Wong(Australian Institute of Tropical Health and Medicine), Ross S. Francis, Mark J. Smyth(Peter MacCallum Cancer Centre), Andrea Schuessler, Scott B. Campbell(The University of Queensland), George Ambalathingal(The University of Queensland), John J. Miles(University of Cambridge), Corey Smith(QIMR Berghofer Medical Research Institute)
Cited by 18
Related Papers
Immune surveillance of tumors
|Journal of Clinical Investigation|2007|1.4k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639